Health news round-up: vaccination, testosterone and neighbourhood health The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Three-quarters of pharmacies expect surge in demand for weight-loss pill National Pharmacy Association says the availability of oral semaglutide (Wegovy; Novo Nordisk) “is particularly significant for patients who cannot or do not want to take an injectable medicine”.…
NICE recommends first drug to delay symptoms of type 1 diabetes for NHS use In what has been described as “an extraordinary moment”, teplizumab has been recommended as an immunotherapy for adults and children aged eight years and older with stage two type 1 diabetes mellitus.…
Health news round-up: endocrine research, binge eating on the pill and AI in the NHS The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
Early-onset type 2 diabetes mellitus: identification and management An overview of early-onset type 2 diabetes mellitus, including its pathophysiology, diagnosis and management, as well as approaches for younger adults.…
Health news round up: diabetes, vaping and biologics The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
NICE recommends specific ‘artificial pancreas’ for pregnant women with type 1 diabetes The National Institute for Health and Care Excellence said that clinicians should offer training and support with hybrid closed systems for women with type 1 diabetes who are pregnant or planning a pregnancy.…
Staying safe with online pharmacies: what patients and providers need to know about weight-loss prescribing What pharmacy staff and patients should know about weight-loss prescribing, as regulatory communications continue to highlight concerns related to online weight-loss services.…
Best practice for patients taking oral glucocorticoids An overview of the considerations for oral glucocorticoid use, including interactions, side effects and sick day rules.…
